Since MMP-7 showed the highest regulation levels (> 14 FC, p = 5.6 × 10–9) in the proteomics comparison of the groups with AKI 2/3 vs no AKI after LT, we performed a validation using immunohistochemistry. The gene discussed is MMP7; the disease is acute kidney injury.